Effects of X‑ray irradiation in combination with ascorbic acid on tumor control

Hosokawa,Yoichiro; Monzen,Satoru; Yoshino,Hironori; Terashima,Shingo; Nakano,Manabu; Toshima,Keisuke; Saga,Ryo; Kashiwakura,Ikuo

doi:10.3892/mmr.2015.4108

Effects of X‑ray irradiation in combination with ascorbic acid on tumor control

Authors:
- Yoichiro Hosokawa
- Satoru Monzen
- Hironori Yoshino
- Shingo Terashima
- Manabu Nakano
- Keisuke Toshima
- Ryo Saga
- Ikuo Kashiwakura
View Affiliations

Affiliations: Department of Radiation Science, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori 036‑8564, Japan, Department of Bioscience and Laboratory Medicine, Hirosaki University Graduate School of Health Sciences, Hirosaki, Aomori 036‑8564, Japan, Department of Radiology, Akita University Hospital, Akita, Akita 010‑8543, Japan
Published online on: July 22, 2015 https://doi.org/10.3892/mmr.2015.4108
Pages: 5449-5454

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Our previous studies demonstrated that the combination of treatment with ascorbic acid (AsA) and X‑ray irradiation results in increased apoptosis in HL60 cells. The present study was performed to investigate the effects of the combined use of AsA and X‑ray irradiation on epithelial cancer and sarcoma cells, and its potential use in future clinical treatment. X‑ray irradiation combined with AsA treatment resulted in increased suppression of cell growth of HT1080, SAS and A549 cells in vitro compared with X‑ray irradiation alone. The combined treatment also suppressed tumor growth in implanted HT‑1080 cells in vivo. Using annexin V/propidium iodide staining and the detection of activated caspase 3, it was found that X‑ray irradiation increased the apoptotic rate of HT1080 cells and resulted in G2/M arrest. However, apoptosis in the HT1080 cells treated with 5 mM AsA remained unchanged, and no changes were observed in the G2/M fraction. By contrast, AsA treatment caused increased suppression of proliferation compared with X‑ray irradiation. These results suggested that 5 mM AsA slowed the cell cycle and reduced tumor growth. Therefore, X‑ray irradiation combined with AsA treatment may be effective against epithelial cancer and sarcoma cells.

View Figures

View References

1	Cameron E and Pauling L: Ascorbic acid and cancer: a review. Proc Natl Acad Sci USA. 75:4538–3542. 1987. View Article : Google Scholar
2	Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J and Frytak S: Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. N Engl J Med. 301:687–690. 1979. View Article : Google Scholar : PubMed/NCBI
3	Duconge J, Miranda-Massari JR, Gonzalez MJ, Jackson JA, Warnock W and Riordan NH: Pharmacokinetics of vitamin C: insights into the oral and intravenous administration of ascorbate. P R Health Sci J. 27:7–19. 2008.PubMed/NCBI
4	Padayatty SJ, Riordan HD, Hewitt SM, Katz A, Hoffer LJ and Levine M: Intravenously administered vitamin C as cancer therapy: three cases. CMAJ. 174:937–942. 2006. View Article : Google Scholar : PubMed/NCBI
5	Padayatty SJ, Sun AY, Chen Q, Espey MG, Drisko J and Levine M: Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects. PLoS One. 5:e114142010. View Article : Google Scholar : PubMed/NCBI
6	Terashima S, Hosokawa Y, Yoshino H, Yamaguchi M and Nakamura T: Effect of ascorbic acid and X-irradiation on HL-60 human leukemia cells: the kinetics of reactive oxygen species. Oncol Rep. 30:2653–2658. 2013.PubMed/NCBI
7	Shinozaki K, Hosokawa Y, Hazawa M, Kashiwakura I, Okumura K, Kaku T and Nakayama E: Ascorbic acid enhances radiation-induced apoptosis in an HL60 human leukemia cell line. J Radiat Res (Tokyo). 52:229–237. 2011. View Article : Google Scholar
8	Wakasaya T, Yoshino H, Fukushi Y, Yoshizawa A and Kashiwakura I: A liquid crystal-related compound induces cell cycle arrest at the G2/M phase and apoptosis in the A549 human non-small cell lung cancer cell line. Int J Oncol. 42:1205–121. 2013.PubMed/NCBI
9	Chen Q, Espey MG, Sun AY, et al: Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc Natl Acad Sci USA. 104:8749–8754. 2007. View Article : Google Scholar : PubMed/NCBI
10	Takemura Y, Satoh M, Satoh K, Hamada H, Sekido Y and Kubota S: High dose of ascorbic acid induces cell death in mesothelioma cells. Biochem Biophys Res Commun. 394:249–253. 2010. View Article : Google Scholar : PubMed/NCBI
11	Bordignon B, Mones S, Rahman F, Chiron J, Peiretti F, Vidal N and Fontes M: A derivative of ascorbic acid modulates cAMP production. Biochem Biophys Res Commun. 439:137–141. 2013. View Article : Google Scholar : PubMed/NCBI
12	Kam WW and Banati RB: Effects of ionizing radiation on mitochondria. Free Radic Biol Med. 65:607–619. 2013. View Article : Google Scholar : PubMed/NCBI
13	Klingelhoeffer C, Kämmerer U, Koospal M, et al: Natural resistance to ascorbic acid induced oxidative stress is mainly mediated by catalase activity in human cancer cells and catalase-silencing sensitizes to oxidative stress. BMC Complement Altern Med. 12:612012. View Article : Google Scholar : PubMed/NCBI
14	Hoffer LJ, Levine M, Assouline S, et al: Phase I clinical trial of iv ascorbic acid in advanced malignancy. Ann Oncol. 19:1969–1974. 2008. View Article : Google Scholar : PubMed/NCBI
15	Putchala MC, Ramani P, Sherlin HJ, Premkumar P and Natesan A: Ascorbic acid and its pro-oxidant activity as a therapy for tumours of oral cavity - a systematic review. Arch Oral Biol. 58:563–574. 2013. View Article : Google Scholar : PubMed/NCBI
16	Du J, Cullen JJ and Buettner GR: Ascorbic acid: chemistry, biology and the treatment of cancer. Biochim Biophys Acta. 1826:443–457. 2012.PubMed/NCBI
17	Ha YM, Park MK, Kim HJ, Seo HG, Lee JH and Chang KC: High concentrations of ascorbic acid induces apoptosis of human gastric cancer cell by p38-MAP kinase-dependent up-regulation of transferrin receptor. Cancer Lett. 277:48–54. 2009. View Article : Google Scholar
18	Fukumura H, Sato M, Kezuka K, et al: Effect of ascorbic acid on reactive oxygen species production in chemotherapy and hyperthermia in prostate cancer cells. J Physiol Sci. 62:251–257. 2012. View Article : Google Scholar : PubMed/NCBI
19	Witenberg B, Kletter Y, Kalir HH, et al: Ascorbic acid inhibits apoptosis induced by X irradiation in HL60 myeloid leukemia cells. Radiat Res. 152:468–478. 1999. View Article : Google Scholar : PubMed/NCBI
20	Gupta A, Hunt CR, Chakraborty S, et al: Role of 53BP1 in the regulation of DNA double-strand break repair pathway choice. Radiat Res. 181:1–8. 2014. View Article : Google Scholar :
21	Vuyyuri SB, Rinkinen J, Worden E, Shim H, Lee S and Davis KR: Ascorbic acid and a cytostatic inhibitor of glycolysis synergistically induce apoptosis in non-small cell lung cancer cells. PLoS One. 8:e670812013. View Article : Google Scholar : PubMed/NCBI
22	Traber MG and Stevens JF: Vitamins C and E: beneficial effects from a mechanistic perspective. Free Radic Biol Med. 51:1000–1013. 2011. View Article : Google Scholar : PubMed/NCBI
23	Harakeh S, Diab-Assaf M, Khalife JC, et al: Ascorbic acid induces apoptosis in adult T-cell leukemia. Anticancer Res. 27(1A): 289–298. 2007.PubMed/NCBI
24	Stephenson CM, Levin RD, Spector T and Lis CG: Phase I clinical trial to evaluate the safety, tolerability and pharmacokinetics of high-dose intravenous ascorbic acid in patients with advanced cancer. Cancer Chemother Pharmacol. 72:139–146. 2013. View Article : Google Scholar : PubMed/NCBI